Sudden! A pharmaceutical company issued an announcement full of home office

the | Kathy burst! Jilin a pharmaceutical company issued an announcement, because the area was adjusted to a high-risk area, all employees at home office pharmaceutical company issued an announcement, employees at home office yesterday, Jilin Province zhenghe pharmaceutical industry issued a notice that by the impact of the new coronavirus pneumonia outbreak, Jilin Province Tonghua City Dongchang District from January 20, 2021 at 1 a.m. the whole area was adjusted to high-risk areas.
In order to further reduce the flow of people and stop the spread of the epidemic, in accordance with the Law of the People's Republic of China on the Prevention and Control of Infectious Diseases, the Command for the Prevention and Control of The Outbreak of New Coronavirus Pneumonia in Dongchang District has decided that from 22:00 on January 21, 2021, residents of Dongchang District shall not be allowed to go out.
Jilin Province Zhenghe Pharmaceutical Group's main production office is located in Dongchang District, Tonghua City, has started emergency plans, the deployment of epidemic prevention and control and home office work, the situation is now announced as follows: In view of the local epidemic prevention and control situation is complex and serious, is in a critical period, In order to strictly implement the epidemic prevention and control measures, the company decided to start immediately in addition to the original stay-at-home staff of all employees at home office, sales staff and customers to communicate and negotiate the extension of supply, production personnel after the resumption of work in an orderly manner to resume production, overtime to maximize the resumption of production capacity, to ensure supply.
will pay close attention to the dynamics of the epidemic, resolutely implement the requirements of all levels of government for epidemic prevention and control work, strengthen staff self-protection, reasonable arrangements for business activities.
no confirmed or suspected cases have been detected among the company's employees so far.
considering the continuity of the outbreak, which will have an impact on the company's operating results for the current year, we have taken active measures to ensure the smooth operation during the outbreak and minimize losses to the maximum possible.
According to SaibaiLan inquiry, public information shows that Jilin Province Zheng and Pharmaceuticals was established on June 13, 2002, registered capital of 168 million yuan, is a Chinese and Western medicine research and development, the main business is the research and development of Chinese and Western medicine, production and sales (mainly Chinese medicine).
Business scope mainly includes: tablets, hard capsules, granules, pastes, anti-(suppression) bacteria preparations (liquid) (purification) production;
One place is still a medium risk, involving a number of pharmaceutical companies Jilin released data show: January 22, 0-24, Jilin Province, 13 new confirmed cases, 52 new asymptomatic infections - of which, Changchun City, 7 new confirmed cases, 3 asymptomatic infections;
as of 24 hours on January 22, the outbreak in Jilin Province reported a total of 194 confirmed cases, the distribution of confirmed cases is - 138 cases in Tonghua City, 54 cases in Changchun City, Songyuan City 2 cases.
, Jilin Province, the existing asymptomatic infection of 97 cases, the distribution of the situation is: Tonghua City 81 cases, Changchun City 14 cases, Songyuan City 2 cases.
January 23, Tonghua City, Jilin Province held the 10th outbreak prevention and control press conference, the meeting informed that as of January 22 at 24 hours, Tonghua City collected a total of 361,648 samples, of which 88 cases tested positive.
from the above data can be seen, Tonghua City is Jilin this round of high incidence of the epidemic area.
According to the latest statistics of the CDC DISEASE Controller, as of 10 a.m. on January 23, 2021, there are 6 high-risk areas in The whole area of Dongchang District of Tonghua City, Jilin Province.
According to the previous news, on January 18, "Tonghua issued" the "Tonghua City new coronavirus pneumonia outbreak prevention and control command on the Dongchang District, Tonghua Pharmaceutical High-technology Zone 14 areas to adjust to medium-risk areas of the notice."
public information shows that Tonghua Pharmaceutical High-tech Industrial Development Zone is a state-level pharmaceutical high-tech zone, the existing pharmaceutical enterprises 43 households, 7 enterprises have developed into a group company, 2 listed companies, 9 pharmaceutical enterprises have been re-identified as state-level high-tech enterprises, 9 enterprises have obtained provincial certification of enterprise technology centers, of which 3 enterprises have been identified as state-level technology centers.
It is reported that in Tonghua Pharmaceutical High-tech Zone, the scale of the pillar industry of medical and health has been expanding, with the addition of 35 new varieties of health care products, health food and medical devices, with output value up 33.5% YoY, accounting for 59.5% of the region's output value.
90 new cases were reported in Heilongjiang, Hebei, Jilin, Beijing and Shanghai, according to the latest data released by the National Health and Wellness Commission, 31 provinces (autonomous regions, municipalities directly under the Central Government) and Xinjiang Production and Construction Corps reported 107 new confirmed cases on January 22, including 17 cases imported from abroad (Shanghai 8, Shanxi 4, Jiangsu) 2 cases, 1 case in Hunan, 1 case in Guangdong, 1 case in Sichuan), 90 cases in Heilongjiang, 15 cases in Hebei, 13 cases in Jilin, 3 cases in Beijing, 3 cases in Shanghai, 99 new cases of asymptomatic infection (10 cases imported from abroad), 2 new suspected cases, including 1 case of overseas importation (in Shanghai) and 1 case of local cases (in Shanghai).
as of 2400 hours on 22 January, 31 provinces (autonomous regions, municipalities directly under the Central Government) and the Xinjiang Production and Construction Corps had reported 1,750 confirmed cases (of which 85 were serious cases) and 3 suspected cases.
a total of 951,804 close contacts and 36,503 close contacts still under medical observation.
31 provinces (autonomous regions, municipalities directly under the Central Government) and Xinjiang Production and Construction Corps reported 99 new cases of asymptomatic infection (10 cases imported from abroad); 30 cases of confirmed cases were converted to the same day (no foreign importation); 37 cases of medical observation (13 cases of overseas importation) were lifted on the same day; and 961 cases of asymptomatic infection (270 cases of overseas importation) were released from medical observation on the same day.
days ago, China has a number of local aggregation outbreaks, for the Spring Festival return related policies, the latest response of the National Health and Safety Commission is as follows: holding a negative certificate of nucleic acid testing after the start of the Spring Festival travel on January 28, until march 8 after the end of the Spring Festival travel;
if there is fever, dry cough, sore throat, loss of smell (taste), diarrhea and other symptoms of physical discomfort, timely to the hospital.